Longeveron LGVN
NASDAQ LGVN
$0.84 +0.02 (+2.02%)
At close: Aug 21, 2026 · 4:00 PM EDT

Longeveron (LGVN) Cash from Operations (2020 - 2026)

Longeveron (LGVN) posted quarterly Cash from Operations of 4370000.0 for Q1 2026, up 6.96% year-over-year from 4085567.28 in Q1 2025, and up 17.48% quarter-over-quarter from 5296000.0 in Q4 2025.

Longeveron (LGVN) Cash from Operations (2020 - 2026) Analysis & Trends

Longeveron's Cash from Operations history runs 7 years deep, the most recent figure standing at 4370000.0 for Q1 2026.

  • In Q1 2026, Cash from Operations rose 6.96% year-over-year to 4370000.0; the TTM figure through Mar 2026 stood at 18318000.0 (down 18.34% YoY), while the FY2025 annual figure was 18645000.0, down 34.45% from the prior year.
  • Cash from Operations for Q1 2026 stood at 4370000.0, up from 5296000.0 in the prior quarter.
  • The five-year high for Cash from Operations was 2308000.0 in Q4 2022, with the low at 5848000.0 in Q1 2023.
  • The 5-year median for Cash from Operations is 4234000.0 (2022), against an average of 4109058.82.
  • The sharpest annual moves came in 2022 and 2024: Cash from Operations tumbled 80.17% in 2022, then surged 47.23% in 2024.
  • Longeveron's Cash from Operations stood at 2308000.0 in 2022, then slumped by 73.18% to 3997000.0 in 2023, then gained by 15.61% to 3373000.0 in 2024, then slumped by 57.01% to 5296000.0 in 2025, then increased by 17.48% to 4370000.0 in 2026.
  • Business Quant data shows LGVN's Cash from Operations at 4370000.0 in Q1 2026, 5296000.0 in Q4 2025, and 5055000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.13 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 813.00 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -526.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 462.82 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 326.72 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 360.27 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -88.83 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 728.46 Mn
10 Longeveron 26.51 Mn 16.41 Mn 182,000.00 -5.65 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -5.65 Mn
Jun 30, 2026 -5.65 Mn
Mar 31, 2026 -4.37 Mn
Mar 31, 2026 -4.37 Mn
Dec 31, 2025 -5.30 Mn
Dec 31, 2025 -5.30 Mn
Sep 30, 2025 -5.06 Mn
Sep 30, 2025 -5.06 Mn
Jun 30, 2025 -3.60 Mn
Jun 30, 2025 -3.60 Mn
Mar 31, 2025 -4.70 Mn
Mar 31, 2025 -4.70 Mn
Dec 31, 2024 -3.37 Mn
Dec 31, 2024 -3.37 Mn
Sep 30, 2024 -2.84 Mn
Sep 30, 2024 -2.84 Mn
Jun 30, 2024 -4.57 Mn
Jun 30, 2024 -4.57 Mn
Mar 31, 2024 -3.09 Mn
Mar 31, 2024 -3.09 Mn